differentiated thyroid carcinoma
differentiated thyroid carcinoma
Explore linked clinical trials. Standard reference: MONDO:001544723 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer | differentiated thyroid carcinoma | Active, not recruiting | Not applicable | 2026-10-09 | NCT01704586 | |
| Bethesda Classification and Risk Stratification in Differentiated Thyroid Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thyroid Cancer, Papillary, Thyroid Nodule, adenocarcinoma, carcinoma, differentiated thyroid carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, thyroid gland disorder, thyroid gland follicular carcinoma, thyroid tumor | Not yet recruiting | Not stated | 2026-10-05 | NCT07858097 | |
| Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, differentiated thyroid carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gastric cancer, gastric neoplasm, gastroesophageal junction adenocarcinoma, gonadal disorder, head and neck cancer, hepatocellular carcinoma, intestinal disorder, kidney cancer, kidney disorder, liver disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, rectal disorder, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, stomach disorder, transitional cell carcinoma, triple-negative breast carcinoma, urinary system disorder, urothelial carcinoma, uterine disorder | Active, not recruiting | Phase 1 | 2026-10-01 | NCT03170960 | |
| Tracheal Replacement Using A Cryopreserved Aortic Allograft For R0 Resection In Locally Advanced Thyroid Cancer (TRITON 02 Tracheal Replacement In ThyrOid caNcer) | differentiated thyroid carcinoma | Not yet recruiting | Phase 2 | 2026-09-16 | NCT07823686 | |
| Sacituzumab govitEcan in THYroid Cancers | Neoplasms by Histologic Type, carcinoma, differentiated thyroid carcinoma, epithelial neoplasm, neoplasm, thyroid gland undifferentiated (anaplastic) carcinoma | Recruiting | Phase 2 | 2026-09-16 | NCT06235216 | |
| Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, differentiated thyroid carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, poorly differentiated thyroid gland carcinoma, thyroid gland disorder, thyroid gland undifferentiated (anaplastic) carcinoma, thyroid tumor | Active, not recruiting | Phase 1 | 2026-09-02 | NCT07485569 | |
| A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, cancer, central nervous system cancer, central nervous system disorder, differentiated thyroid carcinoma, endocrine system disorder, epithelial neoplasm, glioma, low grade glioma, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant glioma, melanocytic neoplasm, melanoma, neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroepithelial neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, thyroid gland disorder, thyroid tumor | Active, not recruiting | Phase 1 | 2026-09-01 | NCT05538130 | |
| Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thyroid Cancer, Papillary, adenocarcinoma, carcinoma, differentiated thyroid carcinoma, endocrine system disorder, epithelial neoplasm, follicular variant thyroid gland papillary carcinoma, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, poorly differentiated thyroid gland carcinoma, tall cell variant thyroid gland papillary carcinoma, thyroid gland disorder, thyroid gland follicular carcinoma, thyroid gland papillary carcinoma, thyroid tumor | Active, not recruiting | Phase 2 | 2026-07-31 | NCT03914300 | |
| Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) | Head and Neck Neoplasms, Neoplasms by Site, cancer, childhood malignant neoplasm, differentiated thyroid carcinoma, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland carcinoma, thyroid gland disorder, thyroid tumor | Recruiting | Phase 2 | 2026-07-24 | NCT06458036 | |
| Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial | Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thyroid Cancer, Papillary, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, differentiated thyroid carcinoma, endocrine system disorder, epithelial neoplasm, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, papillary adenocarcinoma, primitive neuroectodermal tumor, skin disorder, skin neoplasm, testicular cancer, testicular disorder, thyroid gland disorder, thyroid gland follicular carcinoma, thyroid gland papillary carcinoma, thyroid tumor | Not yet recruiting | Not applicable | 2026-06-24 | NCT07529080 | |
| Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy | differentiated thyroid carcinoma | Recruiting | Not stated | 2026-05-07 | NCT06671184 | |
| Pembrolizumab in High-risk Thyroid Cancer | differentiated thyroid carcinoma | Recruiting | Phase 2 | 2026-04-20 | NCT05852223 | |
| Empirical Radioactive Iodine Therapy in DTC | differentiated thyroid carcinoma | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-05 | NCT07453225 | |
| Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers | differentiated thyroid carcinoma | Recruiting | Not applicable | 2026-03-05 | NCT05604963 | |
| F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Site, differentiated thyroid carcinoma, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Recruiting | Not applicable | 2026-02-27 | NCT07436455 | |
| Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy | differentiated thyroid carcinoma | Active, not recruiting | Not applicable | 2026-02-25 | NCT03416686 | |
| Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy | Head and Neck Neoplasms, Neoplasms by Site, differentiated thyroid carcinoma, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Not yet recruiting | Not stated | 2026-02-10 | NCT06647602 | |
| Iodine Uptake After a Low Iodine Diet | differentiated thyroid carcinoma | Recruiting | Not applicable | 2026-02-06 | NCT05599139 | |
| Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Site, cancer, childhood malignant neoplasm, differentiated thyroid carcinoma, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland carcinoma, thyroid gland disorder, thyroid tumor | Recruiting | Phase 2 | 2025-11-14 | NCT05783323 | |
| Targeted Therapy to Increase RAI Uptake in Metastatic DTC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thyroid Cancer, Papillary, adenocarcinoma, carcinoma, childhood malignant neoplasm, differentiated thyroid carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, thyroid gland disorder, thyroid tumor | Recruiting | Not stated | 2025-11-14 | NCT05024929 | |
| A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thyroid Cancer, Papillary, adenocarcinoma, carcinoma, differentiated thyroid carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, thyroid cancer, nonmedullary, 2, thyroid gland disorder, thyroid gland follicular carcinoma, thyroid tumor | Active, not recruiting | Phase 3 | 2025-09-25 | NCT03690388 | |
| Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer | differentiated thyroid carcinoma | Recruiting | Phase 2 | 2025-08-24 | NCT06359847 | |
| Primary Care Transfer for Thyroid Cancer Patients | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, differentiated thyroid carcinoma | Active, not recruiting | Not applicable | 2024-10-03 | NCT03794375 |